Press releases Press releases Year None2020201920182017201620152014 Sep 02, 2020 Otonomy to Participate in Four Upcoming Investor Conferences Aug 04, 2020 Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update Aug 03, 2020 Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program Jul 28, 2020 Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update Jul 13, 2020 Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jul 09, 2020 Otonomy Announces Pricing of $60.1 Million Public Offering Jul 08, 2020 Otonomy Announces Proposed Public Offering Jul 06, 2020 Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 in Patients with Tinnitus Jul 06, 2020 Otonomy Provides Update on OTIVIDEX® Program Jun 15, 2020 Otonomy Provides Update on Clinical Trials and Development Programs Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
